Plasma Nf-L levels and GFAP levels were increased in most participants (8/10 and 7/10, respectively) relative to median levels in a healthy control sample, indicating that neuronal and glial alterations are possibly common to most DM1 participants; however, lack of a control sample in this study limits our interpretation. The gene discussed is NEFL; the disease is myotonic dystrophy type 1.